← Back to the feed
Earnings9267Genky DrugStores Co.,Ltd. · TSE Prime

Genky Drugstores Reports Q3 Revenue of 160 billion, Up 10%

– Genky Drugstores Co., Ltd. (9267.T) reported consolidated results for Q3 FY2026 (ending June 2026).

Revenue was ¥160 billion (+9.7% YoY). operating profit was ¥8,022 million (+17.3%). net profit attributable to shareholders was ¥5,621 million (+15.4%).

Total assets stood at ¥140 billion with an equity ratio of 41.4%. The company declared an annual dividend of ¥6 per share. The full-year forecast for the current fiscal year is revenue of ¥220 billion (+10.2%).

Financial results — FY2026/6 (consolidated)

MetricCurrentYoY
Revenue¥161,710M+9.7%
Operating profit¥8,022M+17.3%
Net profit¥5,621M+15.4%

Next period forecast

Revenue

¥221,200M

+10.2%

Op. profit

¥11,050M

+14.4%

Net profit

¥7,850M

+11.1%

Source: TDNet filing · Figures in millions of yen

PDFOriginal disclosureTDnet filing · Japanese · 15:30 JSTView original ↗
End of article